Cargando…

Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients

Introduction: Pelvic hypoperfusion caused by atherosclerosis has been proposed as a cause of lower urinary tract dysfunction including overactive bladder syndrome (OAB). Limited data indicate that OAB patients with concomitant diabetes or hypertension, known risk factors of atherosclerosis, may exhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müderrisoglu, A. Elif, Sakul, Ayse A., Murgas, Sandra, de la Rosette, Jean J. M. C. H., Michel, Martin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097919/ https://www.ncbi.nlm.nih.gov/pubmed/37063295 http://dx.doi.org/10.3389/fphar.2023.1144470

Ejemplares similares

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
por: Müderrisoglu, A. Elif, et al.
Publicado: (2022)

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses
por: Michel, Martin C., et al.
Publicado: (2022)

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany
por: Murgas, Sandra, et al.
Publicado: (2019)

Urinary Bladder Weight and Function in a Rat Model of Mild Hyperglycemia and Its Treatment With Dapagliflozin
por: Yesilyurt, Zeynep Elif, et al.
Publicado: (2019)

NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
por: Liao, Kuang-Ming, et al.
Publicado: (2022)

Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting
por: Amiri, Marjan, et al.
Publicado: (2021)

Overactive bladder induces transient hypertension
por: Torimoto, Kazumasa, et al.
Publicado: (2018)

Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study
por: Michel, Martin C., et al.
Publicado: (2020)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Effect of caffeine on bladder function in patients with overactive bladder symptoms
por: Lohsiriwat, Supatra, et al.
Publicado: (2011)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Solifenacin significantly improves all symptoms of overactive bladder syndrome
por: CHAPPLE, C R, et al.
Publicado: (2006)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms
por: Al-Shaiji, Tariq F., et al.
Publicado: (2011)

Overactive Bladder is a Distress Symptom in Heart Failure
por: Son, Youn-Jung, et al.
Publicado: (2018)

Effect of sacrocolpopexy and retropubic sling on overactive bladder symptoms
por: Aslam, Muhammad Faisal, et al.
Publicado: (2017)

Seasonal Variation of Overactive Bladder Symptoms in Female Patients
por: Tae, Bum Sik, et al.
Publicado: (2019)

The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms
por: Iwaniak, Paulina, et al.
Publicado: (2023)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
por: Gong, Qin-Qin, et al.
Publicado: (2020)

Daidzein is the in vivo active compound of Puerariae Lobatae Radix water extract for muscarinic receptor-3 inhibition against overactive bladder
por: Qiang, Yining, et al.
Publicado: (2022)

Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder
por: Lee, Seung Hwan, et al.
Publicado: (2014)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Factors affecting medication discontinuation in patients with overactive bladder symptoms
por: Shim, Eun-Jung, et al.
Publicado: (2015)

Impact of smoking habit on overactive bladder symptoms and incontinence in women
por: Kawahara, Takashi, et al.
Publicado: (2020)

Overactive bladder symptom score – translation and linguistic validation in Bengali
por: Pal, Manidip, et al.
Publicado: (2022)

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)

Does confinement affect symptoms and bother of overactive bladder patients?
por: Ortiz Salvador, Juan Bautista, et al.
Publicado: (2023)

Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry
por: Daan, N. M. P., et al.
Publicado: (2012)

Netupitant, a Potent and Highly Selective NK(1) Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs
por: Palea, Stefano, et al.
Publicado: (2016)

Validation of the Arabic linguistic version of the Overactive Bladder Symptoms Score questionnaire
por: Elbaset, M. A., et al.
Publicado: (2019)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Hengli(®) Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Liao, Limin, et al.
Publicado: (2022)

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder
por: Cardozo, Linda, et al.
Publicado: (2014)

Muscarinic cholinergic signaling and overactive bladder-like symptoms associated with invasive bladder cancer
por: Wei, Wei, et al.
Publicado: (2018)

The efficacy of nebivolol on spontaneously hypertensive rats with overactive bladder – an experimental study
por: Wróbel, Andrzej F., et al.
Publicado: (2019)

AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
por: Yang, Bo
Publicado: (2016)

O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment
por: Wróbel, Andrzej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sffaskfaud3asua1ouj16lnh2v